High Flow O2 Devices -

Last update images today High Flow O2 Devices

Silva: Euro '24 QF Not Just Ronaldo Vs. Mbappé

The international swimming federation says its executive director has been ordered to testify as a witness in a U.S. criminal investigation into the case of 23 Chinese swimmers who tested positive for a banned substance in 2021 yet were allowed to continue competing.

Swimming's world governing body, World Aquatics, told The Associated Press on Thursday that its top administrator, Brent Nowicki, was subpoenaed to testify in the investigation.

"World Aquatics can confirm that its executive director, Brent Nowicki, was served with a witness subpoena by the United States government," World Aquatics said in a statement to the AP. "He is working to schedule a meeting with the government, which, in all likelihood will obviate the need for testimony before a Grand Jury."

World Aquatics declined to answer questions about where and when Nowicki was served his subpoena and didn't say which office was handling the investigation. The FBI did not immediately return requests for comment.

The news comes just three weeks before the Paris Olympics, where 11 of the Chinese swimmers who tested positive for a banned heart medication three years ago are set to compete.

The swimmers in question were allowed to compete at the Tokyo Olympics despite their positive tests just months before those Games. Chinese officials blamed food contamination; the World Anti-Doping Agency accepted that explanation and has since defended its handling of the case.

China won six medals in swimming, including three golds, at the Tokyo Olympics to finish fourth on the medal table behind the United States, Australia and Britain.

The positive tests were not publicly known until The New York Times and German broadcaster ARD first reported on the case in April.

A House Committee on China asked the Justice Department and FBI on May 21 to investigate the case under a federal law that allows investigations into suspected doping conspiracies even if they occurred outside the U.S.

Information from Reuters was used in this report.

Airvo Introduction 500x500
Airvo Introduction 500x500
High Flow Oxygen Therapy Mobile Stage 4 3
High Flow Oxygen Therapy Mobile Stage 4 3
Hfno System
Hfno System
Intubated Patient Laying In Bed
Intubated Patient Laying In Bed
A321258 1 En 52 Fig2 HTML
A321258 1 En 52 Fig2 HTML
149423 High Flow O2 Therapy
149423 High Flow O2 Therapy
Maxresdefault
Maxresdefault
96059
96059
HFNC 1副本
HFNC 1副本
High Flow Nasal Oxygen Therapy Device 1000x1000
High Flow Nasal Oxygen Therapy Device 1000x1000
DcTJZcwW0AAVVGx  Large
DcTJZcwW0AAVVGx Large
Airvo 2 Highflow Oxygen Therapy 500x500
Airvo 2 Highflow Oxygen Therapy 500x500
Jor 01 00018 G001 550 ?1626762576
Jor 01 00018 G001 550 ?1626762576
Jcm 12 06685 G001
Jcm 12 06685 G001
Airwaymgmt HamiltonMed HighFlowOxygen 1500
Airwaymgmt HamiltonMed HighFlowOxygen 1500
F2.large
F2.large
High Flow Oxygen Devices
High Flow Oxygen Devices
Maxresdefault
Maxresdefault
97a3290b24cdf3d01874983b0804d9e4
97a3290b24cdf3d01874983b0804d9e4
Gr1 Lrg
Gr1 Lrg
ICU One Pager Nasal O2
ICU One Pager Nasal O2
Oxygen Delivery Devices And Flow Rates Infographic
Oxygen Delivery Devices And Flow Rates Infographic
Optimal Niv Masthead Thumb
Optimal Niv Masthead Thumb
Airvo2
Airvo2
98883e769c8cbafd349b4994f6
98883e769c8cbafd349b4994f6
Equipment Used For The Nasal High Flow Oxygen Therapy System We Used A PMH 2000 Heated
Equipment Used For The Nasal High Flow Oxygen Therapy System We Used A PMH 2000 Heated
Hfnc Schematic
Hfnc Schematic
F1.large
F1.large
4ef5c04bb148e71fae3164ca10b57be1
4ef5c04bb148e71fae3164ca10b57be1
Maxresdefault
Maxresdefault
5fc72b8ba2ec57466
5fc72b8ba2ec57466
Management Comparison Devices Flow Delivery Original
Management Comparison Devices Flow Delivery Original
57a19a524414b58516d9881994b2074b
57a19a524414b58516d9881994b2074b